Find a Therapeutic By Name

Search By Attributes

Therapy Type

Combination
DNA/RNA-based
Immunotherapy (active)
Immunotherapy (passive)
Other
Procedural Intervention
Small Molecule
Supplement, Dietary

Condition

Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Cerebral Amyloid Angiopathy
Frontotemporal Dementia
Mild Cognitive Impairment
Parkinson's Disease

Keyword

2 Therapeutics

Search Results

Name	Synonyms	FDA Status	Company	Target Type	Therapy Type	Approved For
ALPHA-1062	GLN-1062 , Memogain	Alzheimer's Disease (Phase 3)	Alpha Cognition, Galantos Pharma	Cholinergic System	Small Molecule
KarXT	xanomeline-trospium	Alzheimer's Disease (Phase 3)	Karuna Therapeutics	Cholinergic System	Combination, Small Molecule